DG Maximum Strength Redness Relief: Package Insert and Label Information

DG MAXIMUM STRENGTH REDNESS RELIEF- glycerin and naphazoline hydrochloride solution
Dolgencorp, Inc

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Active ingredients

Glycerin 0.5%

Naphazoline hydrochloride 0.03%

Purposes

Glycerin —-Lubricant

Naphazoline hydrochloride —-Redness reliever

Uses

  • For the relief of redness of the eye due to minor eye irritations
  • For the temporary relief of burning and irritation due to dryness of the eye
  • For use as a protectant against further irritation or dryness of the eye

Warnings

For external use only

Do not use if solution changes color or becomes cloudy

Ask a doctor before use if you have narrow angle glaucoma

When using this product

  • To avoid contamination, do not touch tip of container to any surface
  • Replace cap after using
  • Overuse may produce increased redness of the eye
  • Pupils may become enlarged temporarily

Stop use and ask a doctor if

  • you experience eye pain
  • you experience changes in vision
  • you experience continued redness or irritation of the eye
  • the condition worsens or persists for more than 72 hours

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

Instill 1 or 2 drops in the affected eye(s) up to 4 times daily.

Other information

  • store at room temperature
  • remove contact lenses before using
  • Tamper Evident: Do not use this product if imprinted neckband is missing or broken.

Inactive ingredients

benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate

Package Label
(click image for full-size original)

DG MAXIMUM STRENGTH REDNESS RELIEF
glycerin, naphazoline hcl solution
Product Information
Product Type HUMAN OTC DRUG Item Code (Source) NDC:55910-870
Route of Administration OPHTHALMIC DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
GLYCERIN (GLYCERIN) GLYCERIN 0.5 g in 100 mL
NAPHAZOLINE HYDROCHLORIDE (NAPHAZOLINE) NAPHAZOLINE HYDROCHLORIDE 0.03 g in 100 mL
Inactive Ingredients
Ingredient Name Strength
BORIC ACID
SODIUM BORATE
BENZALKONIUM CHLORIDE
WATER
EDETATE DISODIUM
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:55910-870-01 1 BOTTLE, DROPPER in 1 CARTON contains a BOTTLE, DROPPER
1 15 mL in 1 BOTTLE, DROPPER This package is contained within the CARTON (55910-870-01)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
OTC monograph final part349 01/31/2020
Labeler — Dolgencorp, Inc (068331990)
Registrant — K.C. Pharmaceuticals, Inc. (174450460)
Establishment
Name Address ID/FEI Operations
K.C. Pharmaceuticals, Inc. 174450460 manufacture (55910-870), pack (55910-870), label (55910-870)

Revised: 12/2022 Dolgencorp, Inc

DrugInserts.com provides trustworthy package insert and label information about marketed drugs as submitted by manufacturers to the US Food and Drug Administration. Package information is not reviewed or updated separately by DrugInserts.com. Every individual package label entry contains a unique identifier which can be used to secure further details directly from the US National Institutes of Health and/or the FDA.

As the leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. Our material is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2023. All Rights Reserved.